Shanghai Henlius Biotech, Inc. (2696.HK) today announced it has entered into a license agreement with Dr. Reddy's Laboratories SA, wholly-owned subsidiary of Dr. Reddy's Laboratories Ltd., (BSE: ...
First Step to Build a Global Life Insurance Platform at Scale Alongside Consumer Platforms Backed by Differentiated Private Asset Capabilities and Permanent Equity Capital LUXEMBOURG & NEW ...